secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001213900-25-029407
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell appoints Timothy C. Fiori as CFO effective April 7, 2025
-----------------------------------------------------------------

- Fiori served 24 years at IDEXX Laboratories, most recently as Senior Director Finance, Commercial Operations.
- Annual base salary set at $250,000; eligible for company benefit plans and 2017 Stock Option and Incentive Plan.
- Incentive Compensation Agreement provides cash bonuses tied to attainment of specific objectives.
- Press release dated April 7, 2025 furnished as Exhibit 99.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390025029407/0001213900-25-029407-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390025029407/ea0237404-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-029407

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer